LIVERMORE INVESTMENTS GROUP LIMITED
("Livermore" or the "Group")
Appointment of Nominated Adviser
The directors of Livermore are pleased to announce the appointment of Strand Hanson Limited as its Nominated Adviser and Financial Adviser with immediate effect. Arden Partners plc will continue to act as Broker to the Company.
Further to the announcements by Arden Partners Plc on 11 and 14 April 2022 regarding the loss of its nominated adviser status upon the completion of its recommended takeover, the Company has appointed Strand Hanson Limited as its nominated adviser. Given the timing of the completion of the recommended takeover of Arden Partners plc, the London Stock Exchange plc has agreed that subject to initial due diligence being undertaken, Strand Hanson Limited has until 5pm on 27 July 2022 to complete its full due diligence.
There can be no guarantee on the outcome of the full due diligence and its impact on Strand Hanson Limited's decision to continue to act as nominated adviser. Accordingly, in such circumstances there is a risk that if Strand Hanson Limited does not continue to act as nominated adviser following completion of its full due diligence and the Company has not found an alternative nominated adviser, the Company's AIM securities may be suspended pursuant to AIM Rule 1. If within one month of that suspension, the Company has failed to appoint a replacement nominated adviser, the admission of its AIM securities will be cancelled.
Notwithstanding the extension of time provided in respect of completing full due diligence obligations at engagement, Strand Hanson Limited will continue to be subject to all the ongoing nominated adviser responsibilities under the AIM Rules for Nominated Advisers.
For further information please contact:
Livermore Investments Group Limited | |
Gaurav Suri | +41 (0) 43 344 3200 |
| |
Strand Hanson Limited (Financial and Nominated Adviser) | |
Ritchie Balmer, James Spinney | +44 (0) 20 7409 3494 |
| |
Arden Partners plc (Broker) | |
Richard Johnson, Antonio Bossi | +44 (0) 20 7614 5900 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.